For over 50 years, the Hepatology Program at Michigan Medicine has provided state-of-the-art liver care, research, and education. Founded in 1954 by Dr. Keith Henley who was the first to describe alanine aminotransferase (ALT) in serum, which is used throughout the world as a diagnostic tool for liver injury. Dr. Henley, along with Dr. Jeremiah Turcotte (the T of the CTP [Child-Turcotte-Pugh] score that is used to assess severity of liver disease), established the Liver Transplant Program in 1985.
The Hepatology Program faculty is committed to patient education and physician training. The Program has trained a majority of the transplant hepatologists practicing in Michigan.
In addition to providing hepatology training for U-M gastroenterology fellows, the Hepatology Program offers a one-year Transplant Hepatology Fellowship for candidates who have completed an ABIM-certified three-year Gastroenterology Fellowship.
